Latest News about SRPT
Recent news which mentions SRPT
3 Monster Stocks in the Making
November 18, 2023
From Motley Fool
3 Stocks You’ll Regret Not Buying Soon: November 2023
November 16, 2023
From InvestorPlace
Catalent's Q1 Performance Beat Expectations: Analyst Says Main Focus On Manufacturing Outlook For Sarepta's Gene Therapy
November 15, 2023
From Benzinga
Jim Cramer Likes Founder Of AI Company, But Stock Is 'Losing A Fortune' And There's 'Too Much Hype There'
November 15, 2023
From Benzinga
1 Gene Therapy Stock to Buy and Hold for the Long Haul
November 08, 2023
Tickers
SRPT
From Motley Fool
Is It Time to Buy the Nasdaq's 4 Worst-Performing October Stocks?
November 08, 2023
From Motley Fool
8 Health Care Stocks Whale Activity In Today's Session
November 07, 2023
From Benzinga
Sarepta Therapeutics (SRPT) Q3 2023 Earnings Call Transcript
November 02, 2023
Tickers
SRPT
From Motley Fool
Earnings Scheduled For November 1, 2023
November 01, 2023
From Benzinga
From Benzinga
Uphill Battle Ahead For Gene Therapy Player Sarepta, Analysts Lower Price Targets Following Duchenne Trial Miss
October 31, 2023
Tickers
SRPT
From Benzinga
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 31, 2023
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 31, 2023
From Benzinga
Why Are Stocks Down Today?
October 31, 2023
From InvestorPlace
BB Stock Alert: What to Know as BlackBerry Announces CEO Departure
October 31, 2023
From InvestorPlace
US Stocks Fall; Pfizer Swings To Q3 Loss
October 31, 2023
From Benzinga
Why Is Sarepta Therapeutics (SRPT) Stock Down 47% Today?
October 31, 2023
From InvestorPlace
Why Pinterest Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
October 31, 2023
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 31, 2023
From Benzinga
Sarepta/Roche's Closely Watched Duchenne Gene Therapy Faces More FDA Scrutiny - Stock Tanks
October 31, 2023
From Benzinga
From Benzinga
Sarepta Therapeutics shares plunge as gene therapy trial falls short of primary goal
October 31, 2023
From MarketWatch
10 Health Care Stocks With Whale Alerts In Today's Session
October 27, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 25, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 24, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 19, 2023
From Benzinga
3 Gene Editing Stocks to Generate Super-Charged Gains
October 18, 2023
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.